This federal contract was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization that provides blood products and conducts research related to transfusion medicine. The contract, titled "REDS-III" (Recipient Epidemiology and Donor Evaluation Study - III), has a ceiling value of $8,847,513.18 and a period of performance ending on December 31, 2019. The contract does not have a set-aside...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded Vitalant Research Institute a $727,897 delivery order contract to support the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Laboratory program. Under the cost-no-fee contract, Vitalant will provide laboratory services from its facilities in San Francisco, California through December 2019 to assist NIH's ongoing research efforts aimed at improving...
This is a $1,590,903.99 delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) within the Department of Health and Human Services (HHS) to the nonprofit organization Vitalant, doing business as Vitalant Research Institute (VRI). The contract is for the REDS-IV-P Domestic Hubs - Phase 1 project and does not have a set-aside designation. VRI, the research division of Vitalant, is serving as the prime contractor and is partnering with subcontractors including the...
This is a $8,446,747.46 federal delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to Vitalant, a non-profit organization. The contract is for the REDS-IV-P - Center for Transfusion Laboratory Studies (CTLS), Phase 1, which involves necessary testing and serving as the biospecimen repository for the REDS-IV-P program. The University of Colorado-Denver is a major subcontractor on this contract, responsible...
Vitalant Research Institute has been awarded a delivery order against the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute's Recipient Epidemiology and Donor Evaluation Study III (REDS-III) International Sites contract vehicle. This $716,542 cost-no-fee contract will support the REDS-III Phase 3 effort in Brazil. As the prime contractor, Vitalant VRI will leverage its expertise in blood donation and transfusion research to provide...
This is a $2,206,818.78 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Vitalant (formerly Blood Systems), a nonprofit organization, to conduct clinical and epidemiological research on transfusion safety concerns as part of the REDS-IV-P Brazil Phase 1 program. The contract does not have a set-aside designation. Vitalant's research division, the Vitalant Research Institute (VRI), is the prime contractor. VRI has subcontracted with...
This federal contract award, with an ID of 75N92019D00034|75N92024F00001, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the prime contractor Vitalant, a non-profit organization. The contract, valued at $2,104,121.00, is for the REDS-IV-P DOMESTIC HUBS project and does not have a set-aside designation. Vitalant Research Institute (VRI), the research arm of Vitalant, is the prime contractor. VRI has established itself as a key federal partner, providing...
This federal contract award is for the REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2 project, awarded by the National Heart Lung and Blood Institute (NHLBI) to the prime contractor, Vitalant Research Institute (VRI), a nonprofit organization. The $4,908,528.00 cost-type delivery order contract has a completion date of March 31, 2025. VRI, the research arm of the nonprofit blood services provider Vitalant, will conduct the study in collaboration with the University of...
This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Vitalant Research Institute (VRI), the research arm of the nonprofit blood services provider Vitalant. The $2,076,982.30 contract, referred to as REDS-IV-P DOMESTIC HUBS PHASE 2, is for the delivery of various blood products and services to support healthcare programs for veterans, military personnel, and Native American communities....
This is a federal contract award to Vitalant, a nonprofit blood services provider, by the National Heart, Lung, and Blood Institute (NHLBI) for the REDS-IV-P Center for Transfusion Laboratory Studies. The $2,160,438 contract, which does not have a set-aside designation, will support Vitalant's Vitalant Research Institute (VRI) in conducting research and providing laboratory services related to transfusion medicine, blood safety, and infectious diseases. VRI will collaborate with Kaiser...